Cis(Z)‐clopenthixol and clopenthixol (Sordinol®) in chronic psychotic patients: A DOUBLE‐BLIND CLINICAL INVESTIGATION

Acta Psychiatrica Scandinavica

Volumn 58, Issue 5, 1978, Pages 384-388

  Gravem, A ^a,b   Engstrand, E ^a,b   Guleng, R J ^a,b  

^a Dikemark Hospital ^*  (Norway)

^b Reitgjerdet Hospital ^*  (Norway)

Author keywords

cis(Z) clopenthixol; clopenthixol; drug therapy; Schizophrenia; thioxanthene; tranquillizing agent, major

Indexed keywords

CLOPENTHIXOL;

CENTRAL NERVOUS SYSTEM; DRUG COMPARISON; DRUG STRUCTURE; DRUG THERAPY; HUMAN CELL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PSYCHOLOGICAL ASPECT; SCHIZOPHRENIA; THERAPY;

ADULT; AGED; CLINICAL TRIALS; CLOPENTHIXOL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; HUMAN; MALE; MIDDLE AGE; SCHIZOPHRENIA; STEREOISOMERISM; THIOXANTHENES;

EID: 0018221648     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1978.tb03570.x     Document Type: Article

References (5)

1. A study of flupenthixol decanoate and pipothiazine undecylenate in schizophrenics
2. Thioxanthenes